Adaptimmune Therapeutics Plc EV/EBIT
What is the EV/EBIT of Adaptimmune Therapeutics Plc?
The EV/EBIT of Adaptimmune Therapeutics Plc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Adaptimmune Therapeutics Plc
What does Adaptimmune Therapeutics Plc do?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Companies with ev/ebit similar to Adaptimmune Therapeutics Plc
- Progenics Pharmaceuticals has EV/EBIT of N/A
- TUI AG has EV/EBIT of N/A
- Endo International plc has EV/EBIT of N/A
- McNally Bharat Engineering has EV/EBIT of N/A
- Inca One Gold has EV/EBIT of N/A
- NGX International has EV/EBIT of N/A
- Adaptimmune Therapeutics Plc has EV/EBIT of N/A
- Capitol Federal has EV/EBIT of N/A
- Antibe Therapeutics has EV/EBIT of N/A
- Paramount Gold Nevada Corp has EV/EBIT of N/A
- Qualtrics International has EV/EBIT of N/A
- Optical Cable has EV/EBIT of N/A
- Trail Blazer Capital Corp has EV/EBIT of N/A